Related references
Note: Only part of the references are listed.Dynamics of clinical biomarkers as predictors of immunotherapy benefit in metastatic melanoma patients
A. Hernando-Calvo et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2021)
The Pan-Immune-Inflammation Value in Patients with Metastatic Melanoma Receiving First-Line Therapy
Giovanni Fuca et al.
TARGETED ONCOLOGY (2021)
Risk Models for Advanced Melanoma Patients Under Anti-PD-1 Monotherapy-Ad hoc Analyses of Pooled Data From Two Clinical Trials
Xue Bai et al.
FRONTIERS IN ONCOLOGY (2021)
Predictive impact of the inflammation-based indices in uveal melanoma liver metastases treated with transarterial hepatic chemoperfusion
Johannes M. Ludwig et al.
RADIOLOGY AND ONCOLOGY (2021)
The neutrophil-lymphocyte ratio and locoregional melanoma: a multicentre cohort study
Alyss V. Robinson et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials
Giovanni Fuca et al.
BRITISH JOURNAL OF CANCER (2020)
Clinical significance of prognostic nutritional index (PNI) in malignant melanoma
Cem Mirili et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2019)
Systemic immune-inflammation index, SII, for prognosis of elderly patients with newly diagnosed tumors
Chan Li et al.
Oncotarget (2018)
Baseline Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios as Biomarkers of Survival in Cutaneous Melanoma: A Multicenter Cohort Study
Ryckie G. Wade et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Neutrophil to lymphocyte ratio is an independent predictor of outcome for patients undergoing definitive resection for stage IV melanoma
Stefanos Kanatsios et al.
JOURNAL OF SURGICAL ONCOLOGY (2018)
Reference values for white blood-cell-based inflammatory markers in the Rotterdam Study: a population-based prospective cohort study
Jesse Fest et al.
SCIENTIFIC REPORTS (2018)
Prognostic value of Systemic immune-inflammation index in cancer: A meta-analysis
Ruonan Yang et al.
JOURNAL OF CANCER (2018)
Public primary and secondary skin cancer prevention, perceptions and knowledge: an international cross-sectional survey
S. Seite et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)
Systemic Immune-Inflammation Index and Circulating T-Cell Immune Index Predict Outcomes in High-Risk Acral Melanoma Patients Treated with High-Dose Interferon
Jiayi Yu et al.
TRANSLATIONAL ONCOLOGY (2017)
Current status and perspectives in immunotherapy for metastatic melanoma
Riccardo Marconcini et al.
Oncotarget (2017)
Prognostic role of systemic immune-inflammation index in solid tumors: a systematic review and meta-analysis
Jie-Hui Zhong et al.
ONCOTARGET (2017)
High neutrophil to lymphocyte ratio measured before starting ipilimumab treatment is associated with reduced overall survival in patients with melanoma
J. Zaragoza et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
The Growing Burden of Invasive Melanoma: Projections of Incidence Rates and Numbers of New Cases in Six Susceptible Populations through 2031
David C. Whiteman et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: A systematic review and meta-analysis
Tomohiro F. Nishijima et al.
CANCER TREATMENT REVIEWS (2015)
Inflammation Fuels Tumor Progress and Metastasis
Jingyi Liu et al.
CURRENT PHARMACEUTICAL DESIGN (2015)
Prognostic Role of Platelet to Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
Arnoud J. Templeton et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Share Paper
